[ad_1]
A new drug, based on the Tafenoquine molecule, has been approved by the US Food and Drug Administration (FDA). It is used to treat malaria and specifically its recurrent form
This is caused by the parasite Plasmodium vivax, which contaminates 8.5 million people each year. It is a type of malaria that is difficult to eliminate because it can remain dormant in the liver for years and wake up several times. When it wakes up, it can then be transmitted via a mosquito.
In a single dose, the téfénoquine can chase the parasite from the liver and prevent further contamination. In addition, this molecule can be taken with another drug to treat immediate infection.
It was sixty years since a malaria drug had been approved. Professor Ric Price of Oxford University told the BBC that it is a "phenomenal success."
Nevertheless, Tafenoquine can have significant side effects. People with an enzymatic problem or who have a psychiatric illness should not take this medicine at the risk of severe anemia, for example.
Source link
